Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Colonoscopy
100%
Inflammatory Bowel Disease
90%
Crohn's Disease
58%
Colorectal Carcinoma
53%
Occult Blood Test
50%
Neoplasm
37%
Adenoma
36%
Diseases
35%
Recurrent Disease
21%
Manometry
20%
Quality of Life
19%
Tumor Necrosis Factor
16%
Colorectal Tumor
16%
Mercaptopurine
16%
Ulcerative Colitis
15%
Fiber Optics
15%
Screening Program
14%
Polyp
14%
Tumor Necrosis
13%
Colon
13%
Patient with Inflammatory Bowel Disease
13%
Retrospective Cohort Study
12%
Bowel Cancer
12%
Bowel Resection
11%
Colorectal Cancer Screening
11%
Adalimumab
10%
Disease Activity
10%
Randomized Controlled Trial
10%
Pediatrics
9%
Vedolizumab
9%
Diarrhea
9%
Cancer Epidemiology
9%
Family History
9%
Constipation
7%
Malignant Neoplasm
7%
Combination Therapy
7%
Clinician
7%
Irritable Bowel Syndrome
7%
Abdominal Pain
6%
Dysplasia
6%
Cost-Effectiveness Analysis
6%
Drug Dose Reduction
6%
High Resolution Manometry
6%
fertility
6%
Feces
6%
Mental Health
6%
Transitional Care
6%
Cognitive Behavioral Therapy
6%
Complementary Medicine
5%
Family Planning
5%
Nursing and Health Professions
Colonoscopy
85%
Inflammatory Bowel Disease
60%
Colorectal Carcinoma
54%
Occult Blood Test
47%
Neoplasm
39%
Adenoma
32%
Crohn's Disease
29%
Colorectal Tumor
20%
Diseases
19%
Quality of Life
16%
Disease Activity
14%
Practice Guideline
13%
Cohort Analysis
12%
Intestine Cancer
12%
Remission
12%
Occult Blood
11%
Prevalence
10%
Nurse
9%
Longitudinal Analysis
9%
Ulcerative Colitis
9%
Family History
9%
Cancer Screening
9%
Cancer Epidemiology
9%
Adherence
8%
Hemoglobin
8%
Patient with Crohn's Disease
7%
Combination Therapy
7%
Mental Health
7%
Polyp
6%
Patient with Inflammatory Bowel Disease
6%
Sleep Quality
6%
Gastroenterologist
5%
Education
5%
COVID-19
5%
Disease Severity
5%
Diagnostic Accuracy
5%
Health Condition
5%
Disease Exacerbation
5%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammatory Bowel Disease
49%
Mercaptopurine
36%
Crohn's Disease
30%
Remission
17%
Tumor Necrosis Factor
13%
Recurrent Disease
11%
Adalimumab
10%
Allopurinol
10%
Therapeutic Drug Monitoring
10%
Colorectal Carcinoma
9%
Vedolizumab
9%
Ulcerative Colitis
9%
Azathioprine
9%
Diseases
8%
Combination Therapy
7%
Immunosuppressive Agent
6%
Randomized Clinical Trial
5%
Adenoma
5%
Disease Exacerbation
5%